Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,300 warrant series at 1,050 companies. 779 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 3 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 convertible note inducement warrants | $0.5792 | $93.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement agent warrants (Series A-1 Preferred offerings, Q2 2025) | $0.5792 | $93.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Alvogen Warrants (February 7, 2024, $4.00) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Anson First Tranche Warrants (August 14, 2024) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Anson Second Tranche Warrants (October 10, 2024) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Anson Third Tranche Warrants (January 28, 2025) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| April 19, 2024 Underwriter Warrants ($3.63) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Consideration Warrants (March 20, 2025) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| February 28, 2024 Underwriter Warrants ($3.30) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| February 29, 2024 Private Placement Investor Warrants ($3.80) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| First RD Warrants (January 29, 2025) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| March 5, 2024 Underwriter Warrants ($3.30) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| May 23, 2024 Underwriter Warrants ($3.63) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Unitemized residual warrants (incl. Substitute Warrants and pre-2024 series) | $2.45 | $93.1M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| May 2026 PIPE Warrant | $0.9081 | $93.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| PIPE Warrants (Series A Warrants) | $0.9081 | $93.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Tranche 2 Replacement 2029 Warrants (FRE Australia acquisition, AUD 6.70, expiring 2029-09-30) | $4.41 | $92.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Common Stock Warrants (August 2026 Public Offering) | $1.22 | $92.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Pre-Funded Warrants (August 2026 Public Offering) | $1.22 | $92.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2024 common stock warrants issued to financial advisor (Wainwright penny warrants) | $1.40 | $92.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 PIPE investors common stock warrants (Private Placement Warrants) | $1.40 | $92.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 PIPE placement agent common stock warrants (Paulson) | $1.40 | $92.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO placement agent common stock warrants (H.C. Wainwright) | $1.40 | $92.1M | 8-K, Dec 10, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO Series A Warrants – First Closing | $1.40 | $92.1M | DEF 14A, Jul 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO Series A Warrants – Second Closing (K&V) | $1.40 | $92.1M | DEF 14A, Jul 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO Series A Warrants – Third Closing (K&V) | $1.40 | $92.1M | DEF 14A, Jul 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO Series B Warrants – First Closing | $1.40 | $92.1M | DEF 14A, Jul 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO Series B Warrants – Second Closing (K&V) | $1.40 | $92.1M | DEF 14A, Jul 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO Series B Warrants – Third Closing (K&V) | $1.40 | $92.1M | DEF 14A, Jul 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Bridge loan Lender Warrant – First Loan ($2.30) | $1.40 | $92.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Bridge loan Lender Warrant – Second Loan ($1.81) | $1.40 | $92.1M | DEF 14A, Jul 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Historical Kintara common stock warrants | $1.40 | $92.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Legacy TuHURA common stock warrants (residual block, not itemised) | $1.40 | $92.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| PIPE Warrants ($12.00, issued to Alyeska Master Fund, L.P., Feb 24, 2026) | $3.09 | $91.7M | 10-Q, Oct 13, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Public Warrants ($11.50, NUCLW, replacement of SVII public warrants) | $3.09 | $91.7M | 10-Q, Oct 13, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Sponsor Loan-Settlement Private Warrants ($11.50, 2,422,133 issued for settlement of SVII Sponsor loans) | $3.09 | $91.7M | 10-Q, Oct 13, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Sponsor Private Warrants ($11.50, replacement of 7,000,000 SVII private placement warrants) | $3.09 | $91.7M | 10-Q, Oct 13, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| $15 Exercise Price Warrants (Greenland Exploration warrants exchanged into PubCo warrants at the Business Combination) | $2.08 | $91.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| April 2026 Common Warrants ($5.00, GLNDW) | $2.08 | $91.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| ThinkEquity advisory warrants ($10.00, 405,093 shares) | $2.08 | $91.1M | S-1, Apr 10, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Unitemised remainder of 10-K warrant table (outstanding December 31, 2025) | $0.8400 | $90.4M | 10-K, May 20, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Dec ThinkEquity Warrants ($1.5625) | $0.9791 | $90.3M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Jan ThinkEquity Warrants ($2.8125) | $0.9791 | $90.3M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| March 2024 SPA Warrants - Krishnan-Shah Family Partners, LP | $0.9791 | $90.3M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| March 2024 SPA Warrants - Supurna VedBrat (June 2024) | $0.9791 | $90.3M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| March 2024 SPA Warrants - Supurna VedBrat (October 2024) | $0.9791 | $90.3M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Mizuho Warrants ($0.001, amended and restated) | $0.9791 | $90.3M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Public Warrants (public + former Private Placement Warrants, $11.50) | $0.9791 | $90.3M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| HITE pre-funded warrants (September 2026 private placement) | $4.71 | $90.2M | 6-K, Sep 10, 2026Dilution tabAs of Sep 28, 2026 | ||||||||
| Independent director compensation warrants (FY 2025, $4.79) | $4.71 | $90.2M | 20-F, Apr 20, 2026Dilution tabAs of Sep 28, 2026 |
SKYXSKYX Platforms Corp.$0.5792Last price
2023 convertible note inducement warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.7M
SKYXSKYX Platforms Corp.$0.5792Last price
Placement agent warrants (Series A-1 Preferred offerings, Q2 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.7M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
Alvogen Warrants (February 7, 2024, $4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
Anson First Tranche Warrants (August 14, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
Anson Second Tranche Warrants (October 10, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
Anson Third Tranche Warrants (January 28, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
April 19, 2024 Underwriter Warrants ($3.63)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
Consideration Warrants (March 20, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
February 28, 2024 Underwriter Warrants ($3.30)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
February 29, 2024 Private Placement Investor Warrants ($3.80)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
First RD Warrants (January 29, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
March 5, 2024 Underwriter Warrants ($3.30)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
May 23, 2024 Underwriter Warrants ($3.63)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
NRXPNRx Pharmaceuticals, Inc.$2.45Last price
Unitemized residual warrants (incl. Substitute Warrants and pre-2024 series)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.1M
MRLNMerlin, Inc.$0.9081Last price
May 2026 PIPE Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.0M
MRLNMerlin, Inc.$0.9081Last price
PIPE Warrants (Series A Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$93.0M
REARare Earths Americas, Inc.$4.41Last price
Tranche 2 Replacement 2029 Warrants (FRE Australia acquisition, AUD 6.70, expiring 2029-09-30)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.4M
PMVPPMV Pharmaceuticals, Inc.$1.22Last price
Common Stock Warrants (August 2026 Public Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.2M
PMVPPMV Pharmaceuticals, Inc.$1.22Last price
Pre-Funded Warrants (August 2026 Public Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.2M
HURATuHURA Biosciences, Inc.$1.40Last price
2024 common stock warrants issued to financial advisor (Wainwright penny warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 PIPE investors common stock warrants (Private Placement Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 PIPE placement agent common stock warrants (Paulson)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 RDO placement agent common stock warrants (H.C. Wainwright)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 RDO Series A Warrants – First Closing
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 RDO Series A Warrants – Second Closing (K&V)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 RDO Series A Warrants – Third Closing (K&V)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 RDO Series B Warrants – First Closing
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 RDO Series B Warrants – Second Closing (K&V)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
2025 RDO Series B Warrants – Third Closing (K&V)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
Bridge loan Lender Warrant – First Loan ($2.30)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
Bridge loan Lender Warrant – Second Loan ($1.81)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
Historical Kintara common stock warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
HURATuHURA Biosciences, Inc.$1.40Last price
Legacy TuHURA common stock warrants (residual block, not itemised)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$92.1M
NUCLEagle Nuclear Energy Corp.$3.09Last price
PIPE Warrants ($12.00, issued to Alyeska Master Fund, L.P., Feb 24, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$91.7M
NUCLEagle Nuclear Energy Corp.$3.09Last price
Public Warrants ($11.50, NUCLW, replacement of SVII public warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$91.7M
NUCLEagle Nuclear Energy Corp.$3.09Last price
Sponsor Loan-Settlement Private Warrants ($11.50, 2,422,133 issued for settlement of SVII Sponsor loans)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$91.7M
NUCLEagle Nuclear Energy Corp.$3.09Last price
Sponsor Private Warrants ($11.50, replacement of 7,000,000 SVII private placement warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$91.7M
GLNDGreenland Energy Company Common Stock$2.08Last price
$15 Exercise Price Warrants (Greenland Exploration warrants exchanged into PubCo warrants at the Business Combination)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$91.1M
GLNDGreenland Energy Company Common Stock$2.08Last price
April 2026 Common Warrants ($5.00, GLNDW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$91.1M
GLNDGreenland Energy Company Common Stock$2.08Last price
ThinkEquity advisory warrants ($10.00, 405,093 shares)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$91.1M
ARECAmerican Resources Corporation$0.8400Last price
Unitemised remainder of 10-K warrant table (outstanding December 31, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.4M
RDZNRoadzen, Inc.$0.9791Last price
Dec ThinkEquity Warrants ($1.5625)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.3M
RDZNRoadzen, Inc.$0.9791Last price
Jan ThinkEquity Warrants ($2.8125)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.3M
RDZNRoadzen, Inc.$0.9791Last price
March 2024 SPA Warrants - Krishnan-Shah Family Partners, LP
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.3M
RDZNRoadzen, Inc.$0.9791Last price
March 2024 SPA Warrants - Supurna VedBrat (June 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.3M
RDZNRoadzen, Inc.$0.9791Last price
March 2024 SPA Warrants - Supurna VedBrat (October 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.3M
RDZNRoadzen, Inc.$0.9791Last price
Mizuho Warrants ($0.001, amended and restated)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.3M
RDZNRoadzen, Inc.$0.9791Last price
Public Warrants (public + former Private Placement Warrants, $11.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.3M
SWVLSwvl Holdings Corp Class A Common Shares$4.71Last price
HITE pre-funded warrants (September 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.2M
SWVLSwvl Holdings Corp Class A Common Shares$4.71Last price
Independent director compensation warrants (FY 2025, $4.79)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$90.2M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,061 dilution snapshots. 4,846 of 5,300 series state an exercise price and 3,366 an expiry date. 98 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.